Albireo Pharma Inc RPE
¿Qué es el RPE de Albireo Pharma Inc?
El RPE de Albireo Pharma Inc es $441.469k
¿Cuál es la definición de RPE?
Ingresos por empleado (RPE) son ingresos divididos por el número de empleados de una organización.
RPE de compañías en Sector Health Care en NASDAQ en comparadas con Albireo Pharma Inc
¿Qué hace Albireo Pharma Inc?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Empresas con rpe similar a Albireo Pharma Inc
- Sanofi tiene RPE de €440.466k
- Sanofi tiene RPE de €440.466k
- Ashtead Plc tiene RPE de $440.641k
- Baofeng Modern International tiene RPE de ¥440.836k
- GreenSky Inc tiene RPE de $441.290k
- The Heavitree Brewery PLC tiene RPE de £441.375k
- Albireo Pharma Inc tiene RPE de $441.469k
- SB Inc tiene RPE de $441.496k
- LendingTree tiene RPE de $441.727k
- Yu Tak International tiene RPE de HKD$441.739k
- Jiumaojiu International tiene RPE de ¥441.807k
- Anaergia Inc tiene RPE de CAD$441.932k
- AMG Advanced Metallurgical NV tiene RPE de $441.948k